Annual Shareholders Equity
$112.74 M
-$58.77 M-34.26%
December 31, 2023
Summary
- As of February 8, 2025, BOLT annual stockholders equity is $112.74 million, with the most recent change of -$58.77 million (-34.26%) on December 31, 2023.
- During the last 3 years, BOLT annual shareholders equity has risen by +$217.69 million (+207.43%).
- BOLT annual shareholders equity is now -54.93% below its all-time high of $250.12 million, reached on December 31, 2021.
Performance
BOLT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$72.03 M
-$13.83 M-16.11%
September 30, 2024
Summary
- As of February 8, 2025, BOLT quarterly stockholders equity is $72.03 million, with the most recent change of -$13.83 million (-16.11%) on September 30, 2024.
- Over the past year, BOLT quarterly shareholders equity has dropped by -$13.83 million (-16.11%).
- BOLT quarterly shareholders equity is now -76.25% below its all-time high of $303.25 million, reached on March 31, 2021.
Performance
BOLT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
BOLT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.3% | -16.1% |
| 3 y3 years | +207.4% | -16.1% |
| 5 y5 years | +807.1% | -16.1% |
BOLT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.9% | at low | -71.2% | at low |
| 5 y | 5-year | -54.9% | +207.4% | -76.3% | +168.6% |
| alltime | all time | -54.9% | +207.4% | -76.3% | +168.6% |
Bolt Biotherapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $72.03 M(-16.1%) |
| Jun 2024 | - | $85.86 M(-17.6%) |
| Mar 2024 | - | $104.16 M(-7.6%) |
| Dec 2023 | $112.74 M(-34.3%) | $112.74 M(-12.1%) |
| Sep 2023 | - | $128.26 M(-9.8%) |
| Jun 2023 | - | $142.13 M(-9.9%) |
| Mar 2023 | - | $157.69 M(-8.1%) |
| Dec 2022 | $171.51 M | $171.51 M(-9.0%) |
| Sep 2022 | - | $188.45 M(-9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $207.97 M(-8.9%) |
| Mar 2022 | - | $228.39 M(-8.7%) |
| Dec 2021 | $250.12 M(-338.3%) | $250.12 M(-9.0%) |
| Sep 2021 | - | $274.91 M(-7.1%) |
| Jun 2021 | - | $295.90 M(-2.4%) |
| Mar 2021 | - | $303.25 M(-389.0%) |
| Dec 2020 | -$104.95 M(+128.9%) | -$104.95 M(+40.7%) |
| Sep 2020 | - | -$74.59 M(+62.7%) |
| Dec 2019 | -$45.85 M(+187.6%) | -$45.85 M |
| Dec 2018 | -$15.94 M | - |
FAQ
- What is Bolt Biotherapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics annual shareholders equity year-on-year change?
- What is Bolt Biotherapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Bolt Biotherapeutics?
- What is Bolt Biotherapeutics quarterly shareholders equity year-on-year change?
What is Bolt Biotherapeutics annual stockholders equity?
The current annual shareholders equity of BOLT is $112.74 M
What is the all time high annual shareholders equity for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high annual stockholders equity is $250.12 M
What is Bolt Biotherapeutics annual shareholders equity year-on-year change?
Over the past year, BOLT annual stockholders equity has changed by -$58.77 M (-34.26%)
What is Bolt Biotherapeutics quarterly stockholders equity?
The current quarterly shareholders equity of BOLT is $72.03 M
What is the all time high quarterly shareholders equity for Bolt Biotherapeutics?
Bolt Biotherapeutics all-time high quarterly stockholders equity is $303.25 M
What is Bolt Biotherapeutics quarterly shareholders equity year-on-year change?
Over the past year, BOLT quarterly stockholders equity has changed by -$13.83 M (-16.11%)